Summanr The chemoprotective effect of vanadium, a dietary micronutnrent. against chemically induced hepatocarcinogenesis in rats was investigated. Initiation was performed by a single intraperitoneal injection of diethylnitrosamine (DENA; 200 mg kg-') followed by promotion with phenobarbital (0.05 %) in the diet.
Research on the biological influence of vanadium, a ubiquitous transition metal, has grown enormously during the past several years owing to its toxicological impact as an environmental pollutant as well as its role as a dietary trace element (Nechay et al., 1986; Sabbioni et al., 1991 : French and Jones, 1993 Bishayee and Chatterjee, 1994) . Scanning of pertinent literature reveals that many naturally occurring products and trace elements present in various foods may prevent, halt or reverse the neoplastic process (Wattenberg, 1985; Greenwald et al., 1987) . Vanadium, an endogenous constituent of all or most mammalian tissues, is believed to have a regulatory role in biological systems (Crans et al., 1989; Gullapalli et al., 1989) . Studies carried out in the last decade suggest that this transition metal could be considered a representative of a new class of non-platinum group metal anti-tumour agents (Kopf-Maier, 1987) . Although Kingsnorth et al. (1986) observed that vanadate supplementation in diet or drinking water had little or no effect on 1,2-dimethylhydrazine-induced colon cancer in mice. Djordjevic and Wampler (1985) reported a significant antitumour activity of vanadium complexes against L1210 murine leukaemia. Vanadium at > 10-6M inhibited in vitro tumour colony formation, as was evident from a human tumour cloning assay (Hanauske et al., 1987) . Dietary vanadium was found to block the induction of murine mammary carcinogenesis by 1-methyl-l-nitrosourea (Thompson et al., 1984) . Previously, we have documented a significant protective response of vanadium (Sardar et al.. 1993 ) and its possible biochemical mechanism (Chakraborty and Chatterjee, 1994) against the growth of a transplantable murine lymphoma.
In a recent communication, we have reported for the first time that vanadium at 0.5 p.p.m. in drinking water was very effective in arresting the development of diethylnitrosamine Chatterjee, 1995) . The observed chemoprotective action of vanadium was found to be mediated through inhibition of altered liver cell foci and hepatic nodule growth during the early stages of neoplastic transformation (Bishayee and Chatterjee. 1995) . However, in this study vanadium supplementation was done during the entire course of our experiment and it was not possible to ascertain at which time point this trace element was most effective. In order to explore this area, we initiated a new series of experiments in which the anticarcinogenic potential of vanadium was critically examined before the initiation as well as during the early promotion phase of experimentally induced hepatocarcinogenesis. Our present study is an attempt to gain more quantitative information regarding the morphometric analysis of y-glutamyltranspeptidase (GGT)-positive hepatocyte foci and nodules together with remodelling and altered enzyme activities of GGT in the presence or absence of vanadium during DENA-induced hepatocarcinogenesis in rats. The rationale behind the selection of these parameters lies in the fact that hepatocyte foci demonstrating altered enzyme phenotypes including GGT expression are generally accepted to be the putative preneoplastic lesions for hepatocellular carcinoma and their quantitative analysis is a useful tool for evaluation of modulation of hepatocarcinogenesis in rats (Pitot and Sirica. 1980; Farber, 1984a; Williams, 1989 ). We selected DENA as the initiator carcinogen because of its low hepatotoxic and high hepatocarcinogenic properties (Scherer and Emmelot, 1976 ) and for its presence in different food products (Coker et al.. 1991) and tobacco smoke (Serfontein and Hurter. 1966 Morphology, histologyl and histochemistrv After the rats were sacrificed, their livers were promptly excised. blotted, weighed and then examined macroscopically on the surface as well as in 3 mm cross-sections for gross visible persistent nodules (PNs). which represented focal proliferating, GGT-positive hepatic lesions with a low tendency to spontaneous regression (Farber. 1 984b) . The PNs were easily identified from the reddish-brown non-nodular surrounding parenchyma (NNSP) by their greyish-white colour and sharp demarcation. The PNs, which approximated spheres. were measured in two perpendicular directions to the nearest millimetre to obtain an average diameter of each nodule. The PNs were categorised into three groups according to their diameter (namely > 3, < 3 -1 and < I mm) as described by Moreno et al. (1991) . From these diameters, individual nodule volumes were calculated.
Representative sections from right, left and caudate lobes of each liver were taken. They were fixed in an ice-cold mixture of dehydrated ethanol and glacial acetic acid (19:1) for 4 h followed by an overnight incubation in 99.5% ethanol at 4'C and then embedded in soft paraffin (m.p. 47'C) for histological and histochemical examination of liver sections. Two contiguous paraffin sections were made, one for routine haematoxylin and eosin (H&E) staining and one for GGT histochemistry according to the method of Rutenberg et al. (1969) . Quantitative evaluation of GGT-positive hepatic foci (lesions smaller than a liver lobule mainly visible microscopically) were performed as described by Campbell et al. (1982) . Each rat had between 8 and 10 cm2 of liver crosssection examined for GGT transections. and sample identity was unknown during the morphometric analysis. Remodelling lesions were identified as areas lacking uniformity for GGT histochemistry and exhibiting irregular boundaries with surrounding liver and relatively low labelling index (Tatematsu et al.. 1983) . To determine the labelling index of GGT-positive hepatocytes, the rats were given tritiated thymidine (90 Ci mmol' ) i.p. at the dose of 0.5 guCi g-' body weight every 6 h for 48 h before sacrifice. The liver slices were fixed, processed for histochemistry and H&E staining and labelling indices were evaluated according to the procedure of Garcea et al. (1989) 
Results
Food and water intakes During the entire period of our study, no differences in food and water consumption were observed among the various groups of animals. Food and water intakes were 8.7-10.8 g 100-' g day-' and 16.6-18.9 ml 100-' g day-' respectively for all rat groups. Mortality Three rats from different expenrmental groups died before the end of the study (i.e. 20 weeks): two from group A (16.6%) and one from group G (8.3%). None of the rats from any other groups died during the specified period. Table II shows the final body weight, liver weight and relative liver weight of different groups of rats that were killed after 20 weeks of the study. The final body weight of the carcinogen (DENA) control group (group A) was slightly lower (not statistically sigificant) than that of the untreated normal controls (group B). Treatment with vanadium (0.5 p.p.m.) increased the final body weights of animals in groups C. E and G as compared with group A and maintained the normal body weights of animals in groups D, F and H as compared with group B, suggesting that the vanadium supplementation in this study had practically no adverse effect on the growth responses of the rats. There were no significant differences among the groups in their liver weights. On the other hand, the relative liver weight in the rats of group A was found to be significantly higher (P<0.02) than that of group B. Although vanadium supplementation reduced the relative liver weights in groups C. E and G as compared with group A, the result was statistically significant (P <0.05) only in group C. This could be because of a tendency for vanadium-supplemented animals to maintain and recover their body weights faster, showing a better resistance against the aggression manifested by the particular hepatocarcinogenesis model employed and to the smaller number of PNs present in their livers, as indicated in Table III. Effect of vanadium on nodule growth There were no visible hepatocyte nodules in the liver of normal control (group B) as well as vanadium control groups (i.e groups D, F and H). Table III summan'ses the incidence of nodules, total number of nodules and average number per nodule-bearing liver of DENA-treated groups in the presence or absence of vanadium. Significantly decreased (P <0.01) incidence of PNs was observed in the group that received vanadium supplementation throughout the experiment (group C) as compared with the DENA controls (group A). The group which was provided with vanadium only for four successive weeks before initiation (group E) or for 15 consecutive weeks during the promotional event (group G) also exhibited reduced nodule incidence when compared with group A. but the results were statistically insignificant. Although the total number of PNs was found to be much less in the three vanadium-treated groups (i.e. groups C, E and G) than in group A. the result was most pronounced in group C. Similarly. the average number of nodules per nodule-bearing liver (nodule multiplicity) was found to be smaller in groups C. E and G than in group A, but the result was statistically significant only in groups C (P<0.001) and E (P<0.02). (Table V) . A significantly decreased (P<0.01) GGT-positive focal area and percentage of liver parenchyma occupied by foci were also observed in group C as compared with group A. In the presence of vanadium, GGT-positive lesions remodelled to greater extents, as could be seen from the lack of uniformity of GGT histochemistry and irregular outlines (non-uniform foci) coupled with low labelling index (Table V) . However, the results were found to be mostly pronounced and statistically significant in group C as compared with group A.
Body and liver weights
Effect of vanadium on hepatic histology Phenotypically altered hepatocyte populations including PNs were found scattered in the livers of all DENA-treated groups (i.e. groups A, C, E and G) but no such alterations were noticeable in untreated normal controls (group B) or in vanadium controls (i.e. groups D, F and H) (data not shown). The H&E-stained sections of liver slices revealed focal changes that were clearly distinguishable from the surrounding normal parenchyma. In group A, a gross alteration in hepatocellular architecture was found and the hepatocytes appeared oval in shape. The altered hepatocytes of foci and nodules were found to be consistently enlarged with more than one nucleus, which were largely vesiculated. Some nuclei in the cells were large and hyperchromatic with prominent and centrally located nucleoli. Extensive vacuolation was observed in the cytoplasm around the nucleus with masses of acidophilic material. In contrast, the cellular architecture of hepatic lobules seemed to be almost like normal liver in group C, which received vanadium supplementation during the entire period of the study. Liver sections from this group presented only a few clear cell foci. The cells were generally filled with cytoplasmic material and were less vacuolated than group A. The size of the nuclei was essentially the same as that of normal cells, and cells with two nuclei were considerably fewer than in group A. In group E, i.e. the group which received vanadium only before initiation, a predominance of clear rather than acidophilic cell foci was seen. Cells with two nuclei were less common than in group A and the size of the nuclei appeared similar to that of normal cells. However, a moderate improvement in vacuolation and compactness of hepatocytes in group E was evident when compared with group A, but these improvements over group A were of lesser extent as compared with group C. Treatments of rats with vanadium during the promotional phase (group G) only marginally improved the hepatocellular phenotype from group A, as was revealed by histological examination (data not shown).
Effect of vanadium on hepatic enzymatic activity of GGT The enzymatic activity of GGT in the cytosol of PNs induced by DENA alone (group A), as measured quantitatively, was more than 72-fold greater than that found in the liver of untreated controls (group B) and about 2.8-fold higher than in NNSP (Table VI) . Vanadium suppklmentation was found to be effective in reducing the high activity of GGT in both the PNs and NNSP significantly in groups C and E and insignificantly in group G as compared with group A. Here also vanadium-mediated reduction in GGT activity was maximally observed in group C animals. On the other hand, no significant alteration in GGT activity was noticed in vanadium control rats (i.e. groups D, F and H) as compared with their normal counterparts (group B). 
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Discussion
The results of our present investigation clearly demonstrate that in this particular two-stage model of hepatocarcinogenesis in rats the supplementation of 0.5 p.p.m. vanadium during the entire experiment, before initiation and during promotion greatly reduced the incidence, multiplicity and size of visible PNs with a concurrent arrest in the number and spread of GGT-positive hepatic foci in total liver parenchyma. In the promotional event, however, these changes did not have any statistical significance. Our data. thus, reveal the unique protective role of vanadium against chemically induced liver tumorigenesis in rats and corroborate our previous findings (Bishayee and Chatterjee. 1995). This time the anticarcinogenic potential of vanadium is primarily observed on the initiation phase and only secondarily on the promotion stage. In this regard, it is interesting to note that continuous long-term exposure to a low dose of vanadium would elicit a greater protection in terms of the magnitude of preneoplasia than exposure at either the initiation or promotion phase alone. In our experiment. the supplementation of 0.5 p.p.m. vanadium in drinking water, especially during the entire period of the study. resulted in fewer rats developing visible PNs and a smaller number of nodules per nodule-bearing rat liver than those observed in DENA control animals. Another st'king observation of the study was the vanadium-mediated inhibition of the appearance of PNs more than 3 mm in size with a concurrent attenuation of nodular volume as well as nodular volume as a percentage of liver volume. Although it is evident that not all the hepatocyte nodules become cancerous during the lifespan of the animals. numerous observations support the concept that the nodules are the precursors of hepatic cancer (Farber. 1980; Williams. 1980) . Moreover, there is a large body of observational experience in experimental and human disease correlating the number and size of nodular hyperplasia and hepatocarcinoma Cameron. 1980: Farber. 1990 ). In view of this. inhibition of nodule growth and enhancement of their regression by vanadium as observed in our study may be important for cancer prevention. especially if one considers that the PNs are easily recognisable and have a low tendency to regress spontaneously. Again, the food and fluid intakes and changes in body weights among different experimental groups were found to be statistically similar. This feature is of paramount importance because nutritional deprivation causing body weight loss may parallel a decrease in tumour volume (Waitzberg et al.. 1989) . Thus. the observed inhibitory effect of vanadium on nodule appearance and its growth is unlikely to be mediated through the impairment of nutritional status in the experimental animals.
It is generally accepted that GGT-positive foci appear to be the first discernible evidence for the occurrence of tumour initiation (Farber. 1980: Pitot and Sirica. 1980) . Moreover. the use of GGT-positive foci in initiation-promotion bioassay is predicted on the assumption that the incidence of foci correlates with the eventual tumour yield that would have occurred had the assav continued until tumour formation (Farber. 1980 : Pereira. 1982 . In the present study. our results clearly showed an inhibitory role of vanadium on the number of GOT-positive preneoplastic focal lesions per cmn of the livers of rats initiated with DENA. As GGT-positive foci represent a transient step to malignancy (Tatematsu et al.. 1988) . the ability of vanadium to reduce the development of GGT-positive foci suggests that this trace element can greatly affect the initiation stages of hepatocarcinogenesis by preventing the initiated cells from growing into preneoplastic foci through an alteration in the efficiency at which DENA can initiate foci appearance. The potential role of vanadium in reducing the number of foci per cmr of liver area was also reflected through a relatively high remodelling and low labelling index. This strongly indicates that a progressive loss of growth capacity by putative preneoplastic cells and their differentiation into normal-appearing hepatocytes proceed to a greater extent in the presence of vanadium.
According to the well-accepted hypothesis of Pitot et al. (1989) . the number and size of altered liver cell foci indicate initiating and promoting activities respectively. In our study. vanadium supplementation not only decreased the number of GGT-positive preneoplastic foci but also caused a decrement in the focal area with a concomitant reduction in focal area as a percentage of liver area, though the results were statistically more significant with respect to focal number. However. this strongly points out the influence of vanadium in inhibiting or slowing the growth of altered liver cell foci. The observed effect of vanadium on focal growth may represent a selective toxicity to proliferating cells by virtue of the fact that they are proliferating compared with a relatively nonproliferating background and thereby eventually suppress the occurrence of hepatocarcinogenesis. In this regard. it is interesting to note that, although GGT-positive foci appeared in the livers of all the vanadium-treated rats concomitant with DENA administration (foci incidence 100%). only a few rats exhibited PNs in their livers (nodule incidence 41.6-72.7% in the three vanadium-supplemented groups). Since PNs arise from enzyme-altered focal growth (Feo et al.. 1988 ). our present findings could be explained in the light of the fact that. although the precursor lesions were still present in the livers of vanadium-exposed rats. their growth rate slowed to such an extent that appearance of PNs was delayed beyond the experimental end point owing to an increased latency penod. This interpretation is supported by our histological assessment, in which the livers of vanadium-supplemented animals (specially in groups C and E) presented a wellmaintained liver architecture with relatively less acidophilic hepatocyte areas than DENA controls.
The enzymatic activity of GGT has been identified as a possible positive marker for preneoplastic hepatocytes (Cameron et al.. 1978: Hanigan and Pitot. 1985 ). In the current study its activity was measured quantitatively in different cell populations during the induction of liver cancer with DENA in the presence or absence of vanadium. Although GGT activity is located inside the plasma membrane, we performed our study using cytosol as it is generally released in a soluble form by homogenisation. Elhkim et al. (1992) also observed that at least 80% of the total GGT activity was present in the cytosolic fraction. Further. PB is known to be a very weak inducer of GOT alone and, in combination with the initiating carcinogen DENA. the induction increases greatly (Shirai et al.. 1985) . The exponential increase in the activity of GGT in PNs and NNSP following DENA injection as observed here resembled a growth process which onrginated as a response to toxic cellular injury. As there is evidence for a close connection between GGT activation and carcinogenesis (Fiala and Fiala. 1973) . a large increase in this enzyme activity could be correlated with a high nodule incidence, a high total number and a large spread of nodules and foci in hepatic tissue. Vanadiummediated inhibition of GOT-positive hepatocyte foci and PNs during rat liver carcinogenesis initiated with DENA and promoted by PB was well reflected in the relatively low level of this enzymatic activity, which was best observed in the 1219 group in which treatment with vanadium continued throughout the study. This might indicate a change in the plasma membrane of the cells that could be related to the ultimate development of neoplasia. since membrane changes are most easily related theoretically to neoplastic behaviour (Nicolson. 1976) .
DENA and other nitrosamines are thought to confer their carcinogenic action through their metabolic activation, generating DNA-binding alkylating agents (Swenberg et al.. 1991) . Thus. it is likely that the observed inhibitory effect of vanadium on rat liver carcinogenesis may be related to some modification of the metabolic activation and/or detoxification of the particular carcinogen employed. We previously observed that subchronic oral administration of vanadium at very low doses significantly elevates the activity of hepatic and intestinal glutathione S-transferase (GST) in rats (Bishayee and Chatterjee. 1993). GST is a well-known cytosolic phase II enzyme which adds functional groups to the carcinogen, thereby lowering its biological activity and increasing its excretability. Recently, the induction of GST enzyme activity has been suggested to be a protective mechanism of a number of naturally occurring dietary anticarcinogens (Tanaka, 1992; Wattenberg, 1992; Zheng et al.. 1992 : Nijhoff et al., 1993 . The induction of GST by vanadium could lead to enhanced carcinogen elimination as well as a reduction in carcinogen-DNA adduct formation and subsequent expression of preneoplastic lesions and ultimately neoplasia. This may be one of the underlying biochemical mechanisms of the chemopreventive action of this dietary micronutnrent. However, full appreciation of this needs further study.
Regardless of the mechanism, based on the results reported here, vanadium could be considered a potential cancer chemopreventive agent whose effect is presumably based on inhibition of growth of preneoplastic tissue, coupled with its remodelling to normal-appearing liver tissue. This attribute could be considered important, as this trace element may open new perspectives for the clinical therapy of malignancies in human subjects in whom exposure history. genetics or other predisposing events raise the probability of occurrence of cancer to an alarmingly high level.
